The IL-6 and TNF-α levels decreased significantly on day 90 post viral infection, and myocardium fibrosis was ameliorated following blocking of IL-17A using an adenovirus and was accompanied by a significant decrease in viral myocarditis mouse mortality and a significant improvement in heart function. This evidence concerns the gene IL17A and viral myocarditis.